PRODUCTION OF SPECIFIC ANTIBODIES AGAINST GABA-TRANSPORTER SUBTYPES (GAT1, GAT2, GAT3) AND THEIR APPLICATION TO IMMUNOCYTOCHEMISTRY

被引:113
|
作者
IKEGAKI, N [1 ]
SAITO, N [1 ]
HASHIMA, M [1 ]
TANAKA, C [1 ]
机构
[1] KOBE UNIV,SCH MED,DEPT PHARMACOL,KOBE 650,JAPAN
来源
MOLECULAR BRAIN RESEARCH | 1994年 / 26卷 / 1-2期
关键词
GABA TRANSPORTER; IMMUNOCYTOCHEMISTRY; DISTRIBUTION; ANTIBODY; EPENDYMA; ARACHNOID;
D O I
10.1016/0169-328X(94)90072-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Polyclonal subtype-specific antibodies were developed against three subtypes of GABA transporters (GAT1, GAT2 and GAT3). By immunoblot analysis, each antibody detected a single band that could be blocked by absorption of the antibody with the respective antigen. GAT2 was found in various tissues, while GAT1 and GAT3 were detected only in the brain. GAT1 was distributed throughout the brain with the highest amount in the olfactory bulb, CA3 region of the hippocampus, layer I of the cerebral cortex, piriform cortex, superior colliculus, interpeduncular nucleus and nucleus spinal tract of the trigeminal nerve, while the GAT3 was densely found in the olfactory bulb, thalamus, hypothalamus, pens and medulla, globus pallidus, central gray, substantia nigra, deep cerebellar nuclei and nucleus spinal tract of the trigeminal nerve but not in the hippocampus, cerebral cortex, caudate-putamen and cerebellar dorter. GAT2 immunoreactivity was faint throughout the brain but was concentrated in the arachnoid and ependymal cells. Both GAT1 and GAT3 were found in the neuropil but not in the cell bodies nor in the white matter. These results suggest that GAT1, GAT2 and GAT3 are expressed in different cells and that GAT1 and GAT3 are involved in distinct GABAergic transmission while GAT2 may be related to non-neuronal function.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [1] Expression of GABA transporter subtypes (GAT1, GAT3) in the adult rabbit retina
    Hu, M
    Bruun, A
    Ehinger, B
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 (03): : 255 - 260
  • [2] Expression of GABA transporter subtypes (GAT1, GAT3) in the developing rabbit retina
    Hu, M
    Bruun, A
    Ehinger, B
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 1999, 77 (03): : 261 - 265
  • [3] Expression and transport properties of the GABA transporters GAT2, GAT3 and GAT4
    Sachar, A
    Nelson, N
    JOURNAL OF NEUROCHEMISTRY, 2001, 78 : 35 - 35
  • [4] Regulated Trafficking of GABA Transporters, GAT1 and GAT3, in Response to Methamphetamine
    Grote, Hannah R.
    Amara, Susan G.
    Underhill, Suzanne M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [5] Developmental changes in GABA transporter (GAT1 and GAT3) mRNA expressions in the rat olfactory bulb
    Kawamoto, M
    Ohno, K
    Kuriyama, K
    Kubo, T
    Sato, K
    DEVELOPMENTAL BRAIN RESEARCH, 2001, 126 (02): : 137 - 145
  • [6] Neuronal and glial localization of two GABA transporters (GAT1 and GAT3) in the rat cerebellum
    Itouji, A
    Sakai, N
    Tanaka, C
    Saito, N
    MOLECULAR BRAIN RESEARCH, 1996, 37 (1-2): : 309 - 316
  • [7] GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus
    Tih-Shih Lee
    Lars Petter Bjørnsen
    Carlos Paz
    Jung H. Kim
    Susan S. Spencer
    Dennis D. Spencer
    Tore Eid
    Nihal C. de Lanerolle
    Acta Neuropathologica, 2006, 111 : 351 - 363
  • [8] GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus
    Lee, TS
    Bjornsen, LP
    Paz, C
    Kim, JH
    Spencer, SS
    Spencer, DD
    Eid, T
    de Lanerolle, NC
    ACTA NEUROPATHOLOGICA, 2006, 111 (04) : 351 - 363
  • [9] Ion binding and permeation at the GABA transporter GAT1
    Mager, S
    KleinbergerDoron, N
    Keshet, GI
    Davidson, N
    Kanner, BI
    Lester, HA
    JOURNAL OF NEUROSCIENCE, 1996, 16 (17): : 5405 - 5414
  • [10] Inhibition of Activity of GABA Transporter GAT1 by δ-Opioid Receptor
    Pu, Lu
    Xu, Nanjie
    Xia, Peng
    Gu, Quanbao
    Ren, Shuanglai
    Fucke, Thomas
    Pei, Gang
    Schwarz, Wolfgang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012